iBio, Inc. (IBIO) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
iBio, Inc. (IBIO) Bundle
Explore iBio, Inc. (IBIO) financial future with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to calculate iBio, Inc. (IBIO) intrinsic value and shape your investment approach.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.6 | 2.4 | 2.4 | .0 | .2 | .2 | .2 | .1 | .1 | .1 |
| Revenue Growth, % | 0 | 44.75 | 0.50612 | -100 | 0 | -13.69 | -13.69 | -13.69 | -13.69 | -13.69 |
| EBITDA | -11.7 | -18.3 | -25.7 | -28.1 | -14.0 | -.1 | -.1 | -.1 | -.1 | -.1 |
| EBITDA, % | -716.54 | -773.72 | -1079.4 | 100 | -6231.56 | -60 | -60 | -60 | -60 | -60 |
| Depreciation | 2.2 | 2.4 | 3.8 | 1.1 | 1.3 | .2 | .2 | .1 | .1 | .1 |
| Depreciation, % | 136.81 | 101.81 | 159.09 | 100 | 555.56 | 100 | 100 | 100 | 100 | 100 |
| EBIT | -14.0 | -20.8 | -29.5 | -29.2 | -15.3 | -.1 | -.1 | -.1 | -.1 | -.1 |
| EBIT, % | -853.36 | -875.54 | -1238.48 | 100 | -6787.11 | -60 | -60 | -60 | -60 | -60 |
| Total Cash | 55.1 | 97.0 | 33.5 | 4.3 | 14.2 | .2 | .2 | .1 | .1 | .1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 5.6 | 5.5 | 6.1 | .2 | .7 | .2 | .2 | .1 | .1 | .1 |
| Account Receivables, % | 343.35 | 233.07 | 255.98 | 100 | 316.89 | 100 | 100 | 100 | 100 | 100 |
| Inventories | .8 | .0 | 3.9 | 21.1 | .0 | .1 | .1 | .1 | .1 | .1 |
| Inventories, % | 48.72 | 1.14 | 163.66 | 100 | 0 | 49.97 | 49.97 | 49.97 | 49.97 | 49.97 |
| Accounts Payable | 1.8 | 2.3 | 4.3 | 1.8 | .4 | .2 | .2 | .1 | .1 | .1 |
| Accounts Payable, % | 107.39 | 95.07 | 178.93 | 100 | 159.11 | 99.01 | 99.01 | 99.01 | 99.01 | 99.01 |
| Capital Expenditure | -1.2 | -5.2 | -11.6 | -5.7 | -.2 | -.1 | -.1 | -.1 | -.1 | -.1 |
| Capital Expenditure, % | -70.45 | -217.71 | -488.04 | 100 | -93.33 | -72.76 | -72.76 | -72.76 | -72.76 | -72.76 |
| Tax Rate, % | -61.28 | -61.28 | -61.28 | -61.28 | -61.28 | -61.28 | -61.28 | -61.28 | -61.28 | -61.28 |
| EBITAT | -16.1 | -20.8 | -29.9 | -29.2 | -24.6 | -.1 | -.1 | -.1 | -.1 | -.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -19.7 | -22.2 | -40.2 | -47.6 | -4.5 | .2 | .0 | .0 | .0 | .0 |
| WACC, % | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 | 5.09 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .1 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | -1 | |||||||||
| Present Terminal Value | -1 | |||||||||
| Enterprise Value | -1 | |||||||||
| Net Debt | -10 | |||||||||
| Equity Value | 9 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | 2.38 |
What You Will Get
- Editable Forecast Inputs: Effortlessly modify key assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: iBio, Inc.'s (IBIO) financial data pre-loaded to facilitate your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically for you.
- Customizable and Professional: A sleek Excel model designed to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing your time.
Key Features
- Customizable Growth Metrics: Adjust essential variables such as revenue projections, gross margin %, and R&D expenditures.
- Instant DCF Analysis: Automatically computes intrinsic value, NPV, and various financial metrics in real-time.
- High-Precision Results: Leverages iBio’s actual financial data for accurate and reliable valuation insights.
- Streamlined Scenario Simulation: Effortlessly evaluate different scenarios and analyze their impacts.
- Efficiency Booster: Remove the complexity of creating detailed valuation models from the ground up.
How It Works
- Step 1: Download the Excel file for iBio, Inc. (IBIO).
- Step 2: Review the pre-entered data for iBio, including historical and projected figures.
- Step 3: Modify key assumptions (highlighted in yellow) based on your analysis.
- Step 4: Observe the automatic recalculations for iBio’s intrinsic value.
- Step 5: Utilize the results for making investment decisions or for reporting purposes.
Why Choose This Calculator for iBio, Inc. (IBIO)?
- Designed for Experts: A sophisticated tool tailored for analysts, CFOs, and biotech consultants.
- Accurate Data: iBio’s historical and projected financials are preloaded for precise calculations.
- Flexible Scenario Analysis: Effortlessly test various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance ensures a smooth experience throughout the process.
Who Should Use iBio, Inc. (IBIO)?
- Investors: Gain insights into biopharmaceutical advancements with a reliable investment analysis tool.
- Research Analysts: Streamline your evaluation process with comprehensive data on iBio's innovations.
- Consultants: Tailor reports and presentations efficiently by leveraging iBio's market strategies.
- Biotech Enthusiasts: Enhance your knowledge of biotechnology developments through detailed case studies.
- Educators and Students: Utilize iBio's resources as a valuable asset in biotechnology and finance curricula.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations for iBio, Inc. (IBIO).
- Real-World Data: iBio’s historical and projected financials preloaded for in-depth analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
- Dashboard with Visual Outputs: Visualizations and tables for clear, actionable results pertaining to iBio, Inc. (IBIO).